Abstract:Background Unruptured intracerebral aneurysm wall enhancement (AWE) on vessel wall magnetic resonance imaging scans may be a promising predictor for rupture‐prone intracerebral aneurysms. However, the pathophysiology of AWE remains unclear. To this end, the association between AWE and histopathological changes was assessed in this study. Methods and Results A total of 35 patients with 41 unruptured intracerebral aneurysms who underwent surgical clipping were prospectively enrolled. A total of 27 aneurysms were available for histological evaluation. The macroscopic and microscopic features of unruptured intracerebral aneurysms with and without enhancement were assessed. The microscopic features studied included inflammatory cell invasion and vasa vasorum, which were assessed using immunohistochemical staining with CD68, CD3, CD20, and myeloperoxidase for the former and CD34 for the latter. A total of 21 (51.2%) aneurysms showed AWE (partial AWE, n=7; circumferential AWE, n=14). Atherosclerotic and translucent aneurysms were identified in 17 and 14 aneurysms, respectively. Aneurysm size, irregularity, and atherosclerotic and translucent aneurysms were associated with AWE on univariate analysis ( P <0.05). Multivariate logistic regression analysis showed that atherosclerosis was the only factor significantly and independently associated with AWE ( P =0.027). Histological assessment revealed that inflammatory cell infiltration, intraluminal thrombus, and vasa vasorum were significantly associated with AWE ( P <0.05). Conclusions Though AWE on vessel wall magnetic resonance imaging scans may be associated with the presence of atherosclerotic lesions in unruptured intracerebral aneurysms, inflammatory cell infiltration within atherosclerosis, intraluminal thrombus, and vasa vasorum may be the main pathological features associated with AWE. However, the underlying pathological mechanism for AWE still needs to be further studied. Nonstandard Abbreviations and Acronyms AWE aneurysm wall enhancement MPO myeloperoxidase UIA unruptured intracerebral aneurysm Clinical Perspective What Is New? Aneurysm wall enhancement on vessel wall magnetic resonance imaging scans may be associated with atherosclerotic lesions, inflammatory cell infiltration, intraluminal thrombus, and vasa vasorum in unruptured intracerebral aneurysms. What Are the Clinical Implications? We should consider obtaining vessel wall magnetic resonance imaging scans to better understand the pathological characteristics of unruptured intracerebral aneurysms before treatment. However, the underlying pathological mechanism for aneurysm wall enhancement still needs to be further studied. Intracerebral aneurysms (IAs) are histologically characterized by acute and chronic inflammation and vascular wall structure degeneration. 1 , 2 , 3 Increasingly more unruptured IAs have been incidentally discovered and treated, 4 but most of them may be stable and may never rupture over the course of an individual's lifetime. Given the risk associated with treatment and follow‐up observation, it is necessary to evaluate the rupture risk and distinguish rupture‐prone IAs from those that are stable. IAs may undergo morphological changes before rupture 5 —the current predictors identified are mainly based on the patient and aneurysm characteristics, but these have been proven to have limited predictive value. 6 A good predictor for aneurysm rupture should be easily assessed and can reflect pathological changes in the IA. Recently, it has been reported that aneurysm wall enhancement (AWE) on vessel wall magnetic resonance imaging (MRI) scans, indicating wall inflammation, may reflect the cause of subarachnoid hemorrhage in patients with multiple IAs. 7 This imaging finding is also frequently observ -Abstract Truncated-

Vessel wall MRI characteristics of endovascularly treated aneurysms: association with angiographic vasospasm.

Vessel Wall Imaging of Intracranial Aneurysms: Systematic Review and Meta-analysis

Abstract TP182: Vessel Wall MRI in Diagnosis and Prognosis of Intracranial Vasculopathy

A Systematic Review and Meta-Analysis of the Pathology Underlying Aneurysm Enhancement on Vessel Wall Imaging

The Contrast Enhancement of Intracranial Arterial Wall on High-resolution MRI and Its Clinical Relevance in Patients with Moyamoya Vasculopathy

Vessel wall MRI in moyamoya disease: arterial wall enhancement varies depending on age, arteries, and disease progression

Intensity Score of Vessel Wall Contrast Enhancement in MRI Allows Prediction of Disease Progression in Moyamoya Angiopathy

Vessel wall enhancement as a predictor of arterial stenosis progression and poor outcomes in moyamoya disease

Validation of Wall Enhancement As a New Imaging Biomarker of Unruptured Cerebral Aneurysm.

High-resolution MRI vessel wall enhancement in moyamoya disease: risk factors and clinical outcomes

Symptomatic Unruptured Arteriovenous Malformations: Focal Edema, Thrombosis, and Vessel Wall Enhancement: A Retrospective Cohort Study

Vessel wall imaging features of Moyamoya disease in a North American population: patterns of negative remodelling, contrast enhancement, wall thickening, and stenosis

Association of intracranial vessel wall enhancement and cerebral hemorrhage in moyamoya disease: a high-resolution magnetic resonance imaging study

In vivo intravascular MR imaging: transvenous technique for arterial wall imaging.

Vessel wall enhancement of a ruptured intra-nidal aneurysm in a brain arteriovenous malformation

Aneurysmal Wall Enhancement and Hemodynamics: Pixel-Level Correlation Between Spatial Distribution

Relationship Between Aneurysm Wall Enhancement and Conventional Risk Factors in Patients with Unruptured Intracranial Aneurysms: A Black-Blood MRI Study.

Optimizing timing for quantification of intracranial aneurysm enhancement: a multi-phase contrast-enhanced vessel wall MRI study

Association of intravascular enhancement sign detected on high-resolution vessel wall imaging with ischaemic events in middle cerebral artery occlusion

Wall enhancement predictive of abnormal hemodynamics and ischemia in vertebrobasilar non-saccular aneurysms: a pilot study

Aneurysm Wall Enhancement in Unruptured Intracranial Aneurysms: A Histopathological Evaluation.